Scientific Publications

Our research contributions to the field of computational biology

108 publications

Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.

Carmen Dumea, Dalila Belei, Alina Ghinet, Joëlle Dubois, Amaury Farce, Elena Bîcu
Bioorganic & medicinal chemistry letters December 2014 Vol. 24(24) Pages: 5777-5781

The rational structural modification of new substituted indolizin-3-yl(phenyl)methanones 1a-i, 2a-i and 3a-i has greatly improved human farnesyltransferase inhibition. The para-bromophenyl analog 2f bearing an ester unit on the indolizine ring demonstrates the highest inhibition potential, with IC50 value of 1.3±0.2 μM. The amidic series 1a-i proves to be the most …

Relationships between Th1 or Th2 iNKT cell activity and structures of CD1d-antigen complexes: meta-analysis of CD1d-glycolipids dynamics simulations.

Xavier Laurent, Nicolas Renault, Amaury Farce, Philippe Chavatte, Eric Hénon
PLoS computational biology November 2014 Vol. 10(11) Pages: e1003902

A number of potentially bioactive molecules can be found in nature. In particular, marine organisms are a valuable source of bioactive compounds. The activity of an α-galactosylceramide was first discovered in 1993 via screening of a Japanese marine sponge (Agelas mauritanius). Very rapidly, a synthetic glycololipid analogue of this natural …

Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase.

Gina-Mirabela Dumitriu, Alina Ghinet, Elena Bîcu, Benoît Rigo, Joëlle Dubois, Amaury Farce, Dalila Belei
Bioorganic & medicinal chemistry letters July 2014 Vol. 24(14) Pages: 3180-5

Novel phenothiazine derivatives bearing an amino acid residue were synthesized via peptide chemistry, and evaluated for their inhibitory potential on human farnesyltransferase. The phenothiazine unit proved to be an important bulky unit in the structure of the synthesized inhibitors. Propargyl ester 20 bearing a tyrosine residue exhibited the best biological …

Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular bases.

Xavier Laurent, Benjamin Bertin, Nicolas Renault, Amaury Farce, Silvia Speca, Ophélie Milhomme, Régis Millet, Pierre Desreumaux, Eric Hénon, Philippe Chavatte
Journal of medicinal chemistry July 2014 Vol. 57(13) Pages: 5489-508

Since the discovery in 1995 of α-galactosylceramide 1 (α-GalCer), also known as KRN7000,1 hundreds of compounds have been synthesized in order to activate invariant natural killer T (iNKT) cells. Such keen interest for this lymphocyte cell type is due to its ability to produce different cytokines that bias the immune …

Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.

Cristina-Maria Abuhaie, Alina Ghinet, Amaury Farce, Joëlle Dubois, Benoît Rigo, Elena Bîcu
Bioorganic & medicinal chemistry letters November 2013 Vol. 23(21) Pages: 5887-92

A new family of 30 benzoylated N-ylides 4 and 5 was synthesized and evaluated for the inhibitory activity on human protein farnesyltransferase. Most of these novel compounds possessed in vitro inhibition potencies in the micromolar range. The nature of the substituents on the pyridine and phenyl units proved to be …

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

Aurélien Tourteau, Virginie Andrzejak, Mathilde Body-Malapel, Lucas Lemaire, Amélie Lemoine, Roxane Mansouri, Madjid Djouina, Nicolas Renault, Jamal El Bakali, Pierre Desreumaux, Giulio G Muccioli, Didier M Lambert, Philippe Chavatte, Benoît Rigo, Natascha Leleu-Chavain, Régis Millet
Bioorganic & medicinal chemistry September 2013 Vol. 21(17) Pages: 5383-94

Recent investigations showed that anandamide, the main endogenous ligand of CB1 and CB2 cannabinoid receptors, possesses analgesic, antidepressant and anti-inflammatory effects. In the perspective to treat inflammatory bowel disease (IBD), our approach was to develop new selective CB2 receptor agonists without psychotropic side effects associated to CB1 receptors. In this …

Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes.

Angeliki Karamitri, Nicolas Renault, Nathalie Clement, Jean-Luc Guillaume, Ralf Jockers
Molecular endocrinology (Baltimore, Md.) August 2013 Vol. 27(8) Pages: 1217-33

The existence of interindividual variations in G protein-coupled receptor sequences has been recognized early on. Recent advances in large-scale exon sequencing techniques are expected to dramatically increase the number of variants identified in G protein-coupled receptors, giving rise to new challenges regarding their functional characterization. The current minireview will illustrate …

Synthesis and biological evaluation of fluoro analogues of antimitotic phenstatin.

Alina Ghinet, Aurélien Tourteau, Benoît Rigo, Vivien Stocker, Marie Leman, Amaury Farce, Joëlle Dubois, Philippe Gautret
Bioorganic & medicinal chemistry June 2013 Vol. 21(11) Pages: 2932-40

With the aim of investigating the influence of fluorine, in particular on the A-ring, a new series of fluoro analogues (7a-l) of phenstatin (3) was synthesized and tested for interactions with tubulin polymerization and evaluated for cytotoxicity on an NCI-60 human cancer cell lines panel. We have shown that the …

Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features.

Nicolas Renault, Xavier Laurent, Amaury Farce, Jamal El Bakali, Roxane Mansouri, Philippe Gervois, Régis Millet, Pierre Desreumaux, Christophe Furman, Philippe Chavatte
Chemical biology & drug design April 2013 Vol. 81(4) Pages: 442-54

The relevance of CB(2)-mediated therapeutics is well established in the treatment of pain, neurodegenerative and gastrointestinal tract disorders. Recent works such as the crystallization of class-A G-protein-coupled receptors in a range of active states and the identification of specific anchoring sites for CB(2) agonists challenged us to design a reliable …

Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.

Cristina-Maria Abuhaie, Elena Bîcu, Benoît Rigo, Philippe Gautret, Dalila Belei, Amaury Farce, Joëlle Dubois, Alina Ghinet
Bioorganic & medicinal chemistry letters January 2013 Vol. 23(1) Pages: 147-52

A new family of microtubule-targeting agents with a phenothiazine A-ring was synthesized and evaluated for anti-proliferative activity and interaction with tubulin. These new derivatives showed significant activities against cellular proliferation and tubulin polymerization, rather similar to those of phenstatin. Phenothiazine derivative 21 proved to be the most potent compound synthesized …

Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.

Valérie Verones, Nathalie Flouquet, Marie Lecoeur, Amelie Lemoine, Amaury Farce, Brigitte Baldeyrou, Christine Mahieu, Nicole Wattez, Amélie Lansiaux, Jean-François Goossens, Pascal Berthelot, Nicolas Lebegue
European journal of medicinal chemistry January 2013 Vol. 59 Pages: 39-47

The synthesis of new acridinone and dioxophenothiazine derivatives along with their tubulin polymerization inhibitory and antiproliferative activities is reported. The analysis of correlation for cytotoxic and antitubulin potential of tested compounds showed that 4-methoxyphenylethyl derivatives 18a and 19a were highly cytotoxic but were regarded to have no significant antitubulin activity. …

Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.

Cristina-Maria Abuhaie, Alina Ghinet, Amaury Farce, Joëlle Dubois, Philippe Gautret, Benoît Rigo, Dalila Belei, Elena Bîcu
European journal of medicinal chemistry January 2013 Vol. 59 Pages: 101-10

Two new families of human farnesyltransferase inhibitors 13a-m and 14a-d, based on a phenothiazine scaffold, were synthesized. Compounds 14a and 14b were the most promising inhibitors of human farnesyltransferase with IC(50) values of 0.7 and 0.6 μM, respectively.

Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity.

Morgan Le Naour, Veronique Leclerc, Amaury Farce, Daniel-Henri Caignard, Nathalie Hennuyer, Bart Staels, Valérie Audinot-Bouchez, Jean-Albert Boutin, Michel Lonchampt, Catherine Dacquet, Alain Ktorza, Pascal Berthelot, Nicolas Lebegue
ChemMedChem December 2012 Vol. 7(12) Pages: 2179-93

Compounds that simultaneously activate peroxisome proliferator-activated receptor (PPAR) subtypes α and γ have the potential to effectively treat dyslipidemia and type 2 diabetes (T2D) in a single pharmaceutically active molecule. The frequently observed side effects of selective PPARγ agonists, such as edema and weight gain, were expected to be overcome …

Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.

Lavinia Baciu-Atudosie, Alina Ghinet, Amaury Farce, Joëlle Dubois, Dalila Belei, Elena Bîcu
Bioorganic & medicinal chemistry letters November 2012 Vol. 22(22) Pages: 6896-902

A new family of protein farnesyltransferase inhibitors, based on a phenothiazine scaffold, was designed and synthesized. The biological evaluation of these products showed that compounds 28 and 30 were the most active, with protein farnesyltransferase inhibition potencies in the low micromolar range. Compounds were also evaluated for their antiproliferative activity …

Antioxidant activity of new benzo[de]quinolines and lactams: 2D-quantitative structure-activity relationships.

Alina Ghinet, Amaury Farce, Souhila Oudir, Jean Pommery, Joseph Vamecq, Jean-Pierre Henichart, Benoît Rigo, Philippe Gautret
Medicinal chemistry (Shariqah (United Arab Emirates)) September 2012 Vol. 8(5) Pages: 942-6

In order to predict the antioxidant activity of 7 polycyclic lactams, a two dimensional quantitative-structure activity relationships (2D-QSAR) study based on a 5-descriptor model was performed. The synthetic compounds built from a condensed lactam scaffold were screened for their abilities to inhibit the autoxidation of pyrogallol, a superoxide anion radical-dependent …

Mixed metallic Ba(Co,Fe)X(0.2)O(3-δ) (X = F, Cl) hexagonal perovskites: drastic effect of Fe-incorporation on structural and electronic features.

Mihaela Iorgulescu, Pascal Roussel, Nathalie Tancret, Nicolas Renault, Florence Porcher, Gilles André, Houria Kabbour, Olivier Mentré
Inorganic chemistry July 2012 Vol. 51(14) Pages: 7598-608

Starting from the parent 10H-Ba(5)Co(5)X(1-x)O(13-δ) (trimeric strings of face-sharing CoO(6) octahedra with terminal CoO(4) tetrahedra, stacking sequence (chhch')(2)) and 6H-Ba(6)Co(6)X(1-x)O(16-δ) (similar with tetrameric strings, stacking sequence chhhch') hexagonal perovskites forms (X = F, Cl; c, h = [BaO(3)] layers ; h' = [BaOX(1-y)] layers), we show here that the Fe …

New farnesyltransferase inhibitors in the phenothiazine series.

Dalila Belei, Carmen Dumea, Alexandrina Samson, Amaury Farce, Joëlle Dubois, Elena Bîcu, Alina Ghinet
Bioorganic & medicinal chemistry letters July 2012 Vol. 22(14) Pages: 4517-22

The biological screening of the chemical library of our Organic Chemistry Department, carried out on an automated fluorescence-based FTase assay, allowed us to discover that a phenothiazine derivative (1d) was an inhibitor of farnesyltransferase. Three new series of human farnesyltransferase inhibitors, based on a phenothiazine scaffold, were synthesized with protein …

Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.

Antonio Garofalo, Amaury Farce, Séverine Ravez, Amélie Lemoine, Perrine Six, Philippe Chavatte, Laurence Goossens, Patrick Depreux
Journal of medicinal chemistry February 2012 Vol. 55(3) Pages: 1189-204

In our continuing search for medicinal agents to treat proliferative diseases, quinazoline derivatives were synthesized and evaluated pharmacologically as epithelial growth factor receptor and vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitors. A quantitative structure-activity relationship analysis was conducted to rationalize the structure-activity relationship and to predict how …

Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population.

Christian L Lino Cardenas, Nicolas Renault, Amaury Farce, Christelle Cauffiez, Delphine Allorge, Jean-Marc Lo-Guidice, Michel Lhermitte, Philippe Chavatte, Franck Broly, Dany Chevalier
Gene November 2011 Vol. 487(1) Pages: 10-20

The CYP4A subfamily is known to ω-hydroxylate the endogenous arachidonic acid into 20-hydroxyeicosatetranoic acid, which has renovascular and tubular functions. The aim of this work was to report a comprehensive investigation of the CYP4A11 and CYP4A22 genetic polymorphisms in a French population. Using PCR-SSCP and sequencing strategies, a total of …